Kuala Lumpur, 18 May 2020: Shanghai Liangrun Biomedicine Technology Co Ltd first batch of product arrived in Malaysia on 18 May 2020.
Shanghai Liangrun have since April 3 2020 appointed Nexgram Industries Sdn Bhd as the authorised distributor of antibody IgM/IgG Covid-19 diagnostic kit in Malaysia and Indonesia, dedicated Nexgram Industries to register the product with Medical Device Authority (MDA) Malaysia.
Nexgram Industries is a wholly-owned subsidiary of Nexgram Holdings Bhd (NEXGRAM).
Shanghai Liangrun is a company principally engaged in biomedicine technology, while Tri-G is the licensed medical device distributor in Malaysia in collaboration with a network of more than 5,000 medical providers nationwide.
TRIG is a licensed medical device distributor and had obtained Malaysia master authorisation to distribute Novel Coronavirus (2019-nCoV) IgM/IgG Rapid Test Kit, and Novel Coronavirus (2019-nCoV) RT-qPCR Detection and Diagnostic Kit. TRIG is currently already distributing Malaysia Medical Device Authority (MDA) special access approved Novel Coronavirus (2019-nCoV) IgM/IgG Rapid Test Kit to medical centres right after 18 March 2020 the start of movement control order (MCO).
ABOUT NEXGRAM HOLDINGS BHD
NEXGRAM HOLDINGS BERHAD is listed on the ACE Market of Bursa Malaysia Exchange and its headquarter is in Malaysia. The group is a diversified investment company having businesses in IT, security and surveillance, logistics, property and other industries.
ABOUT TRI-G TECHNOLOGIES SDN BHD
Tri-G is a MDA licensed medical supplies distributor with GDPMD certificate in Malaysia. The company is in collaboration with a network of more than 5,000 medical providers nationwide.
Nexgram Covid-19 AID Team (NCA)